Shanghai Fosun Pharmaceutical said on Friday that it and Henan Genuine Biotech will cooperate with multiple companies to expand production of the COVID treatment Azvudine.

China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.

Shanghai Fosun Pharmaceutical said on Monday it would cooperate with its charity fund and Henan Genuine Biotech to donate 100 million yuan worth of COVID treatment Azvudine to China's rural areas.

Genuine Biotech rec'd China approval on Monday for use of HIV drug in Covid-19 treatment. ... More logo. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) ...

Genuine Biotech's drug, Azvudine, was initially developed as a treatment for HIV and Beijing approved the drug for that purpose last July. But, when the pandemic hit, Genuine Biotech began ...

Genuine Biotech Co. Ltd.’s azvudine has been granted conditional approval by China’s NMPA for the treatment of COVID-19. The drug, first granted conditional approval from the NMPA to treat ...

China's medical products regulator said on Monday it grants conditional approval to Genuine Biotech's treatment Azvudine to treat adult patients with COVID-19. The greenlight by the National ...

BEIJING -- China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against ...

Shanghai Fosun Pharmaceutical said on Monday it would cooperate with its charity fund and Henan Genuine Biotech to donate 100 million yuan worth of COVID treatment Azvudine to China's rural areas.

BEIJING, Jan 20 (Reuters) - Shanghai Fosun Pharmaceutical 600196.SS said on Friday that it and Henan Genuine Biotech will cooperate with multiple companies to expand production of the COVID ...